<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Clofibrat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:45 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Clofibrat_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Clofibrat_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Clofibrat_files/filelist.xml">
<title>CLOFIBRAT</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>5</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:02:00Z</o:Created>
  <o:LastSaved>2006-08-09T05:19:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1199</o:Words>
  <o:Characters>6839</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>56</o:Lines>
  <o:Paragraphs>16</o:Paragraphs>
  <o:CharactersWithSpaces>8022</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>CLOFIBRAT<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tên
chung qu&#7889;c t&#7871;:</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> Clofibrate.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC</span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: C10A
B01.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c:</span></b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'> Thu&#7889;c h&#7841; lipid máu (nhóm fibrat).<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nang 500
mg.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofibrat
là thu&#7889;c ch&#7889;ng t&#259;ng lipid máu. Thu&#7889;c làm h&#7841; lipid
huy&#7871;t thanh b&#7857;ng cách gi&#7843;m lipoprotein t&#7927; tr&#7885;ng r&#7845;t
th&#7845;p (VLDL) gi&#7847;u triglycerid. Có th&#7875; làm gi&#7843;m
cholesterol huy&#7871;t thanh, &#273;&#7863;c bi&#7879;t &#7903; nh&#7919;ng
ng&#432;&#7901;i cholesterol t&#259;ng do có m&#7863;t lipoprotein t&#7927; tr&#7885;ng
trung gian (IDL) trong ch&#7913;ng t&#259;ng lipoprotein máu typ III. C&#361;ng
có th&#7875; làm t&#259;ng nh&#7865; lipoprotein t&#7927; tr&#7885;ng cao
(HDL). C&#417; ch&#7871; tác d&#7909;ng ch&#432;a &#273;&#432;&#7907;c xác
&#273;&#7883;nh rõ. Clofibrat có th&#7875; &#7913;c ch&#7871; gi&#7843;i phóng
các lipoprotein &#7903; gan (&#273;&#7863;c bi&#7879;t là VLDL), làm t&#259;ng
tác d&#7909;ng c&#7911;a lipoprotein lipase và t&#259;ng bài xu&#7845;t các
sterol trung tính &#7903; phân. Clofibrat có th&#7875; làm gián &#273;o&#7841;n
sinh t&#7893;ng h&#7907;p cholesterol tr&#432;&#7899;c ch&#7863;ng t&#7841;o
mevalonat.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofibrat
làm gi&#7843;m n&#7891;ng &#273;&#7897; triglycerid huy&#7871;t thanh nhi&#7873;u
h&#417;n gi&#7843;m n&#7891;ng &#273;&#7897; cholesterol huy&#7871;t thanh; do
&#273;ó thu&#7889;c không có hi&#7879;u qu&#7843; cho nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh ch&#7881; t&#259;ng &#273;&#417;n thu&#7847;n cholesterol. S&#7917;
d&#7909;ng clofibrat trong ch&#7913;ng t&#259;ng lipoprotein máu typ II c&#361;ng
h&#7841;n ch&#7871; vì tác d&#7909;ng th&#7845;t th&#432;&#7901;ng trên
cholesterol. Không khuy&#7871;n cáo dùng r&#7897;ng rãi clofibrat trong c&#7897;ng
&#273;&#7891;ng &#273;&#7875; d&#7921; phòng b&#7879;nh tim thi&#7871;u máu c&#7909;c
b&#7897;.<i><o:p></o:p></i></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
&#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofibrat
&#273;&#432;&#7907;c h&#7845;p thu d&#7877; dàng và g&#7847;n nh&#432; hoàn
toàn &#7903; &#273;&#432;&#7901;ng tiêu hóa. Thu&#7889;c &#273;&#432;&#7907;c
các enzym huy&#7871;t thanh th&#7911;y phân nhanh chóng thành acid t&#7921; do
là acid clofibric, ch&#7845;t có ho&#7841;t tính c&#7911;a clofibrat . N&#7891;ng
&#273;&#7897; &#273;&#7881;nh trong huy&#7871;t t&#432;&#417;ng c&#7911;a acid
clofibric 4 - 6 gi&#7901; sau khi u&#7889;ng m&#7897;t li&#7873;u duy nh&#7845;t
500 mg clofibrat &#7903; ng&#432;&#7901;i kh&#7887;e m&#7841;nh kho&#7843;ng 49
- 53 microgam/ml. Kho&#7843;ng 95 - 98% acid clofibric liên k&#7871;t v&#7899;i
protein huy&#7871;t t&#432;&#417;ng. N&#7917;a &#273;&#7901;i th&#7843;i tr&#7915;
c&#7911;a acid clofibric kho&#7843;ng 12 - 35 gi&#7901; (trung bình là 12 - 22
gi&#7901;) &#7903; ng&#432;&#7901;i l&#7899;n kh&#7887;e m&#7841;nh và 29 - 88
gi&#7901; &#7903; ng&#432;&#7901;i suy th&#7853;n. X&#7845;p x&#7881; 95 - 99%
li&#7873;u u&#7889;ng clofibrat bài ti&#7871;t vào n&#432;&#7899;c ti&#7875;u &#7903;
d&#7841;ng acid clofibric t&#7921; do và liên h&#7907;p.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofibrat
&#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh cho ch&#7913;ng lo&#7841;n beta
lipoprotein máu tiên phát (t&#259;ng lipid máu typ III) không &#273;áp &#7913;ng
&#273;&#7847;y &#273;&#7911; v&#7899;i ch&#7871; &#273;&#7897; &#259;n.
Clofibrat dùng trong &#273;i&#7873;u tr&#7883; ng&#432;&#7901;i b&#7879;nh
tr&#432;&#7903;ng thành có n&#7891;ng &#273;&#7897; triglycerid huy&#7871;t
thanh r&#7845;t cao (t&#259;ng lipid máu typ IV và V) có nguy c&#417; &#273;au
b&#7909;ng và viêm t&#7909;y (&#273;i&#7875;n hình là nh&#7919;ng ng&#432;&#7901;i
có n&#7891;ng &#273;&#7897; triglycerid huy&#7871;t thanh cao trên 2000 mg/dl)
mà không &#273;áp &#7913;ng &#273;&#7847;y &#273;&#7911; v&#7899;i ch&#7871;
&#273;&#7897; &#259;n và gi&#7843;m u&#7889;ng r&#432;&#7907;u và &#7903;
ng&#432;&#7901;i b&#7879;nh có n&#7891;ng &#273;&#7897; triglycerid huy&#7871;t
thanh t&#7915; 1.000 - 2.000 mg/dl, &#273;ã có ti&#7873;n s&#7917; viêm t&#7909;y
ho&#7863;c &#273;au b&#7909;ng tái phát &#273;i&#7875;n hình c&#7911;a viêm t&#7909;y.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofibrat
không có hi&#7879;u qu&#7843; trong t&#259;ng triglycerid máu &#7903; ch&#7913;ng
t&#259;ng lipid máu typ I &#7903; &#273;ó chylomicron và triglycerid huy&#7871;t
t&#432;&#417;ng t&#259;ng nh&#432;ng l&#7841;i kèm theo hàm l&#432;&#7907;ng
VLDL bình th&#432;&#7901;ng. Quan sát k&#7929; huy&#7871;t t&#432;&#417;ng
&#273;&#7875; t&#7911; l&#7841;nh 12 - 14 gi&#7901;, giúp phân bi&#7879;t có hi&#7879;u
qu&#7843; các typ t&#259;ng lipoprotein máu I, IV và V.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nh&#7919;ng
n&#259;m tr&#432;&#7899;c &#273;ây, clofibrat là thu&#7889;c h&#7841; lipid
&#273;&#432;&#7907;c kê &#273;&#417;n r&#7897;ng rãi nh&#7845;t. Nh&#432;ng vi&#7879;c
s&#7917; d&#7909;ng thu&#7889;c này &#273;ã gi&#7843;m r&#7845;t nhi&#7873;u
sau khi th&#7917; nghi&#7879;m c&#7911;a T&#7893; ch&#7913;c Y t&#7871; th&#7871;
gi&#7899;i cho th&#7845;y m&#7863;c dù h&#7841; &#273;&#432;&#7907;c 9% hàm
l&#432;&#7907;ng cholesterol, nh&#432;ng &#273;i&#7873;u tr&#7883; b&#7857;ng
clofibrat không h&#7841; &#273;&#432;&#7907;c các s&#7921; c&#7889; tim m&#7841;ch
mà còn làm t&#259;ng t&#7927; l&#7879; t&#7917; vong toàn b&#7897; (1978) trong
&#273;ó có t&#7917; vong th&#7913; phát do ph&#7843;i m&#7893; c&#7855;t b&#7887;
túi m&#7853;t vì s&#7887;i m&#7853;t.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá m&#7851;n
v&#7899;i clofibrat .<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Suy gi&#7843;m
n&#7863;ng ch&#7913;c n&#259;ng th&#7853;n ho&#7863;c gan.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>X&#417;
gan &#7913; m&#7853;t tiên phát (dùng clofibrat có th&#7875; làm t&#259;ng
cholesterol máu v&#7889;n &#273;ã t&#259;ng &#7903; nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh này).<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cho t&#7899;i
nay không có b&#7857;ng ch&#7913;ng v&#7919;ng ch&#7855;c là clofibrat có tác d&#7909;ng
làm gi&#7843;m t&#7927; l&#7879; t&#7917; vong tim m&#7841;ch, và vì có th&#7875;
có nh&#7919;ng tác d&#7909;ng ngo&#7841;i ý nghiêm tr&#7885;ng n&#7863;ng (ví d&#7909;
s&#7887;i m&#7853;t, ung th&#432;) liên quan &#273;&#7871;n dùng thu&#7889;c
này, nên clofibrat ch&#7881; &#273;&#432;&#7907;c dùng cho nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh &#273;ã &#273;&#432;&#7907;c ch&#7885;n l&#7921;a c&#7849;n th&#7853;n
(xem ph&#7847;n ch&#7881; &#273;&#7883;nh).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tr&#432;&#7899;c
khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883; v&#7899;i clofibrat, nên
th&#7917; ki&#7875;m soát lipid huy&#7871;t thanh b&#7857;ng ch&#7871; &#273;&#7897;
&#259;n thích h&#7907;p, làm gi&#7843;m cân &#7903; ng&#432;&#7901;i béo phì, t&#7853;p
th&#7875; d&#7909;c, ki&#7875;m soát &#273;ái tháo &#273;&#432;&#7901;ng v.v...
C&#7847;n th&#432;&#7901;ng xuyên &#273;&#7883;nh l&#432;&#7907;ng lipid huy&#7871;t
thanh trong vài tháng &#273;&#7847;u u&#7889;ng clofibrat và sau &#273;ó &#273;&#7883;nh
l&#432;&#7907;ng theo &#273;&#7883;nh k&#7923;. Ph&#7843;i ng&#7915;ng thu&#7889;c
sau 3 tháng n&#7871;u &#273;áp &#7913;ng không &#273;&#7847;y &#273;&#7911;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>S&#7887;i
m&#7853;t có th&#7875; là m&#7897;t tác d&#7909;ng ngo&#7841;i ý c&#7911;a li&#7879;u
pháp clofibrat, vì v&#7853;y ph&#7843;i ti&#7871;n hành nh&#7919;ng th&#7911;
thu&#7853;t ch&#7849;n &#273;oán thích h&#7907;p n&#7871;u xu&#7845;t hi&#7879;n
d&#7845;u hi&#7879;u và tri&#7879;u ch&#7913;ng liên quan &#273;&#7871;n b&#7879;nh
v&#7873; m&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trong th&#7901;i
gian &#273;i&#7873;u tr&#7883; b&#7857;ng clofibrat, ph&#7843;i th&#432;&#7901;ng
xuyên &#273;&#7883;nh l&#432;&#7907;ng transaminase huy&#7871;t thanh và làm
các th&#7917; nghi&#7879;m ch&#7913;c n&#259;ng gan khác, vì có th&#7875; có nh&#7919;ng
b&#7845;t th&#432;&#7901;ng v&#7873; các thông s&#7889; này. N&#7871;u các th&#7917;
nghi&#7879;m ch&#7913;c n&#259;ng gan t&#259;ng b&#7873;n v&#7919;ng ho&#7863;c
có nh&#7919;ng b&#7845;t th&#432;&#7901;ng quá m&#7913;c, thì ph&#7843;i ng&#7915;ng
thu&#7889;c. S&#7917; d&#7909;ng clofibrat ph&#7843;i th&#7853;n tr&#7885;ng &#7903;
nh&#7919;ng ng&#432;&#7901;i b&#7879;nh có ti&#7873;n s&#7917; vàng da ho&#7863;c
b&#7879;nh gan.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ph&#7843;i
&#273;&#7883;nh k&#7923; theo dõi công th&#7913;c máu toàn b&#7897; vì &#273;ã
có thông báo v&#7873; thi&#7871;u máu và gi&#7843;m b&#7841;ch c&#7847;u &#7903;
ng&#432;&#7901;i b&#7879;nh dùng clofibrat.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7863;c
dù không bi&#7871;t clofibrat có th&#7875; gây tác h&#7841;i cho thai nhi khi
ph&#7909; n&#7919; u&#7889;ng trong th&#7901;i gian mang thai hay không, v&#7851;n
c&#7847;n ch&#7889;ng ch&#7881; &#273;&#7883;nh dùng clofibrat cho ph&#7909; n&#7919;
mang thai.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Vì acid
clofibric là ch&#7845;t chuy&#7875;n hóa có ho&#7841;t tính c&#7911;a clofibrat
&#273;&#432;&#7907;c phát hi&#7879;n trong s&#7919;a m&#7865;, nên ch&#7889;ng
ch&#7881; &#273;&#7883;nh dùng thu&#7889;c này cho ph&#7909; n&#7919; cho con
bú.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>ADR
th&#432;&#7901;ng g&#7863;p nh&#7845;t là các tri&#7879;u ch&#7913;ng tiêu hóa
nh&#7845;t th&#7901;i, &#7881;a ch&#7843;y và gi&#7843;m kh&#7843; n&#259;ng
tình d&#7909;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#432;&#7901;ng
g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Chung:
Gi&#7843;m kh&#7843; n&#259;ng tình d&#7909;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tiêu
hóa: Ðau b&#7909;ng, khó tiêu, bu&#7891;n nôn, &#7881;a ch&#7843;y.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Gan: S&#7887;i
m&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Chung:
Nh&#7913;c &#273;&#7847;u, m&#7887;i m&#7879;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>C&#417;
x&#432;&#417;ng: B&#7879;nh c&#417;, &#273;au c&#417; bao g&#7891;m tri&#7879;u
ch&#7913;ng/ h&#7897;i ch&#7913;ng gi&#7889;ng viêm c&#417; và tiêu c&#417;
vân.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hi&#7871;m
g&#7863;p, ADR &lt; 1/1000<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Chung:
Chóng m&#7863;t, t&#259;ng cân.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Da: Ban da, ng&#7913;a.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Gan: T&#259;ng transaminase.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Khác: R&#7909;ng lông, tóc. Gi&#7843;m b&#7841;ch c&#7847;u
trung tính, m&#7845;t b&#7841;ch c&#7847;u h&#7841;t và lo&#7841;n nh&#7883;p
tim &#273;ã &#273;&#432;&#7907;c thông báo &#7903; ng&#432;&#7901;i b&#7879;nh
&#273;i&#7873;u tr&#7883; b&#7857;ng clofibrat .<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Li&#7873;u l&#432;&#7907;ng và cách
dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>U&#7889;ng t&#7915; 1,5 &#273;&#7871;n 2 gam m&#7895;i
ngày, chia làm 2 - 4 l&#7847;n. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Nên u&#7889;ng clofibrat cùng v&#7899;i th&#7913;c
&#259;n &#273;&#7875; gi&#7843;m r&#7889;i lo&#7841;n tiêu hóa.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tránh ph&#7889;i h&#7907;p clofibrat v&#7899;i các thu&#7889;c
ch&#7889;ng &#273;ông lo&#7841;i dicoumarol/warfarin: Dùng cùng v&#7899;i
clofibrat có th&#7875; làm t&#259;ng &#273;áng k&#7875; tác d&#7909;ng ch&#7889;ng
&#273;ông; n&#7871;u dùng, c&#7847;n &#273;i&#7873;u ch&#7881;nh li&#7873;u thu&#7889;c
ch&#7889;ng &#273;ông d&#7921;a vào k&#7871;t qu&#7843; xác &#273;&#7883;nh
th&#432;&#7901;ng xuyên th&#7901;i gian prothrombin. M&#7897;t s&#7889; nhà lâm
sàng khuyên nên gi&#7843;m thu&#7889;c ch&#7889;ng &#273;ông xu&#7889;ng m&#7897;t
n&#7917;a li&#7873;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thu&#7889;c u&#7889;ng ch&#7889;ng &#273;ái tháo
&#273;&#432;&#7901;ng, &#273;&#7863;c bi&#7879;t là tolbutamid: Dùng cùng
clofibrat có th&#7875; làm t&#259;ng tác d&#7909;ng h&#7841; &#273;&#432;&#7901;ng
huy&#7871;t, do clofibrat &#273;&#7849;y các thu&#7889;c này ra kh&#7887;i v&#7883;
trí liên k&#7871;t v&#7899;i albumin huy&#7871;t t&#432;&#417;ng và nh&#432; v&#7853;y
có th&#7875; c&#7847;n ph&#7843;i &#273;i&#7873;u ch&#7881;nh li&#7873;u c&#7911;a
chúng. Glipizid và glyburid, do có &#273;&#7863;c tính liên k&#7871;t không ion
nên có th&#7875; không b&#7883; &#7843;nh h&#432;&#7903;ng nhi&#7873;u nh&#432;
các thu&#7889;c u&#7889;ng ch&#7889;ng &#273;ái tháo &#273;&#432;&#7901;ng
khác, tuy nhiên n&#7871;u dùng cùng v&#7899;i clofibrat, c&#361;ng nên th&#7853;n
tr&#7885;ng).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Chenodesoxycholic ho&#7863;c ursodesoxycholic: Có th&#7875;
b&#7883; gi&#7843;m tác d&#7909;ng n&#7871;u dùng cùng v&#7899;i clofibrat vì
clofibrat có khuynh h&#432;&#7899;ng làm t&#259;ng bão hòa cholesterol &#7903;
m&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Các ch&#7845;t &#7913;c ch&#7871; HMG - CoA reductase
dùng cùng v&#7899;i clofibrat có th&#7875; làm t&#259;ng nguy c&#417; b&#7883;
tiêu c&#417; vân, m&#7863;c dù ch&#432;a có thông báo v&#7873; các ca tiêu
c&#417; vân khi dùng clofibrat cùng v&#7899;i các ch&#7845;t &#7913;c ch&#7871;
HMG - CoA reductase; tuy nhiên &#273;ã có thông báo v&#7873; các ca tiêu
c&#417; vân khi dùng fibrat khác (gemfibrozil) cùng v&#7899;i lovastatin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Probenecid dùng cùng v&#7899;i clofibrat có th&#7875; làm
gi&#7843;m thanh th&#7843;i chuy&#7875;n hóa và thanh th&#7843;i th&#7853;n, và
làm thay &#273;&#7893;i m&#7913;c liên k&#7871;t c&#7911;a clofibrat v&#7899;i
protein huy&#7871;t t&#432;&#417;ng, do &#273;ó làm t&#259;ng tác d&#7909;ng
&#273;i&#7873;u tr&#7883; và &#273;&#7897;c tính c&#7911;a clofibrat.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Rifampicin dùng cùng v&#7899;i clofibrat có th&#7875; làm
t&#259;ng chuy&#7875;n hóa c&#7911;a clofibrat b&#7857;ng cách c&#7843;m &#7913;ng
các enzym microsom &#7903; gan, k&#7871;t qu&#7843; là h&#7841; &#273;áng k&#7875;
n&#7891;ng &#273;&#7897; clofibrat trong huy&#7871;t thanh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Các thu&#7889;c u&#7889;ng tránh thai, n&#7871;u dùng
&#273;&#7891;ng th&#7901;i, có th&#7875; thay &#273;&#7893;i hi&#7879;u l&#7921;c
c&#7911;a clofibrat.<o:p></o:p></span></p>

<p class=1nho align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Ð&#7897; &#7893;n &#273;&#7883;nh và
b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ph&#7843;i b&#7843;o qu&#7843;n nang ch&#7913;a clofibrat
l&#7887;ng trong &#273;&#7891; &#273;&#7921;ng &#273;&#7853;y kín, tránh ánh
sáng và &#273;&#7875; &#7903; nhi&#7879;t &#273;&#7897; d&#432;&#7899;i 40<sup>0</sup>C,
t&#7889;t nh&#7845;t là 15 - 30<sup>0</sup>C. Tránh &#273;&#7875; &#273;ông l&#7841;nh
các nang ch&#7913;a ch&#7845;t l&#7887;ng này.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#432;a có thông báo nào v&#7873; quá li&#7873;u. N&#7871;u
x&#7843;y ra, ph&#7843;i dùng các bi&#7879;n pháp h&#7895; tr&#7907; &#273;i&#7873;u
tr&#7883; tri&#7879;u ch&#7913;ng.<o:p></o:p></span></p>

<p class=cach0 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Clofibrat có trong danh m&#7909;c thu&#7889;c thi&#7871;t
y&#7871;u Vi&#7879;t Nam ban hành l&#7847;n th&#7913; 4 n&#259;m 1999.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thu&#7889;c &#273;&#7897;c b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thành ph&#7849;m gi&#7843;m &#273;&#7897;c: Viên 250 mg.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Clofibrat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:45 GMT -->
</html>
